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Neuronal Per-Arnt-Sim (PAS) domain–containing protein 4
(NPAS4) is a basic helix–loop–helix (bHLH)-PAS transcription
factor first discovered in neurons in the neuronal layer of the
mammalian hippocampus and later discovered in pancreatic
-cells. NPAS4 has been proposed as a therapeutic target not
only for depression and neurodegenerative diseases associated
with synaptic dysfunction but also for type 2 diabetes and pan-
creas transplantation. The ability of bHLH-PAS proteins to ful-
fil their function depends on their intracellular trafficking,
which is regulated by specific sequences, i.e. the nuclear local-
ization signal (NLS) and the nuclear export signal (NES). How-
ever, until now, no study examining the subcellular localization
signals of NPAS4 has been published.We show here that Rattus
norvegicus NPAS4 was not uniformly localized in the nuclei of
COS-7 and N2a cells 24 h after transfection. Additionally, cyto-
plasmic localization of NPAS4 was leptomycin B-sensitive. We
demonstrate that NPAS4 possesses a unique arrangement of
localization signals. Its bHLH domain contains an overlapping
NLS and NES. We observed that its PAS-2 domain contains an
NLS, an NES, and a second, proximally located, putative NLS.
Moreover, the C terminus of NPAS4 contains two active NESs
that overlap with a putative NLS. Our data indicate that glucose
concentration could be one of the factors influencing NPAS4
localization. The presence of multiple localization signals and
the differentiated localization of NPAS4 suggest a precise,
multifactor-dependent regulation of NPAS4 trafficking, poten-
tially crucial for its ability to act as a cellular stress sensor and
transcription factor.
Neuronal Per-Arnt-Sim domain–containing protein 4
(NPAS4)2 (also known as neuronal transcription factor (NXF),
limbic-enriched PAS domain protein (LE-PAS), and PAS
domain–containing protein 10 (PASD10)) belongs to the basic
helix–loop–helix (bHLH)-Per-Arnt-Sim (PAS) family of tran-
scription factors (1, 2). This family of proteins is well-conserved
frommetazoans to humans and plays important roles in main-
taining cellular health by acting as environmental sensors (3).
The bHLH-PAS family is divided into two classes according to
the mechanism of dimerization. Class I proteins define the
specificity of target gene activation and form functional het-
erodimers with class II proteins. Aryl hydrocarbon receptors
and hypoxia-inducible factors (HIF, HIF-1, HIF-2, and HIF-
3) are examples of class I proteins. Class II proteins form
homodimers and are general heterodimeric partners for class I
bHLH-PAS proteins. Aryl hydrocarbon nuclear translocator
(ARNT, also known as HIF-1), ARNT2, brain and muscle
ARNT-like 1 (BMAL1, also known as ARNTL), and BMAL2
(ARNTL2) are examples of class II bHLH-PAS proteins (4, 5).
Via a two-hybrid assay, NPAS4 was found to be a class I bHLH-
PAS transcription factor forming functional heterodimers with
ARNT1, ARNT2, and BMAL1 (1). ARNT1 and ARNT2 were
subsequently confirmed as heterodimeric partners ofNPAS4 in
the brain (6).
NPAS4 was first discovered in mammalian neurons in the
neuronal layer of the hippocampus (6) and later detected in
nonneuronal tissues.NPAS4was shown to be highly induced by
activity and stress in pancreatic -cells, to reduce insulin con-
tent, to impair responsiveness to glucagon-like peptide 1 (GLP-
1), and to protect pancreatic -cells from ER stress (7). Inter-
estingly, expression of NPAS4 was also documented in human
endothelial cells. Esser et al. (8) presentNPAS4 as a regulator of
blood vessel formation and a factor necessary for endothelial
cell function such as migration, sprouting, and branch forma-
tion in constructing new vasculature.
NPAS4 has been proposed as a novel therapeutic target for
depression and neurodegenerative diseases associated with
synaptic dysfunction (9), as a component of new stroke thera-
pies (10), as a therapeutic target for diabetes (11), and as a treat-
ment during pancreas transplantation (12). NPAS4 has also
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been shown to enhance autophagic clearance of the total and
phosphorylated pools of endogenous Tau protein in primary
cortical neurons, implicating NPAS4 as a potential therapeutic
target for neurodegenerative tauopathies such as Alzheimer’s
disease (13).
Eukaryotic cells possess distinct nuclear and cytoplasmic
compartments separated by a double-membrane nuclear enve-
lope with nuclear pore complexes, which allow the exchange of
macromolecules between these two compartments (14). To
enable transcriptional responses, intra- or extracellular signals
need to be transmitted to the nucleus; nucleocytoplasmic shut-
tling of transcription factors is a mechanism involved in this
process (15). Nuclear pore complexes allow passive diffusion of
ions and small proteins (40 kDa) through the nuclear enve-
lope, but passage of larger molecules is restricted to those con-
taining appropriate targeting signals recognized by specific car-
rier proteins known as karyopherins. Karyopherins engaged in
nuclear import are known as importins, and those engaged in
export from the nucleus are known as exportins (16). Subcellu-
lar localization and shuttling of proteins between nuclear and
cytoplasmic compartments are consequences of a dynamic bal-
ance between operational strengths of nuclear localization sig-
nals (NLS) and nuclear export signals (NES) (14). It has been
shown that leptomycinB (LMB) inhibits protein transport from
the nucleus to the cytoplasm by interacting with exportin 1,
which depends on a leucine-enriched sequence known as the
classical NES (17–19).
The subcellular localization of NPAS4 was first reported in a
study examining full-length NPAS4 48 h after transfecting
COS-7 cells, revealing a strict nuclear localization of this pro-
tein (2). Analyses performed in HEK293 cells 48 h after trans-
fection yielded a similar result (20). However, Sullivan et al. (21)
show by immunofluorescent staining of fixed HEK293T cells
24 h after transfection that NPAS4 even though most staining
was nuclear, some stainingwas also presented in the cytoplasm.
Additionally,Western blot analysis of samples obtained by sub-
cellular fractionation of rat coronal brain tissue reveal NPAS4
expression not only in the nucleus but also in the cytoplasm of
cells. Ischemic insult resulted in partial translocation of NPAS4
from the cytoplasm to intracellular membranes. Moreover, in
that study, NPAS4 was also detected in microsomal and synap-
tosomal fractions (20). These findings suggest that NPAS4 con-
tains motifs that direct its localization to different cellular
compartments.
In our present study, we sought to perform a detailed char-
acterization of the subcellular localization motifs of NPAS4
protein. We found that 24 h after transfection, NPAS4 was
exchanged between the nucleus the and cytoplasm in COS-7
and Neuro 2a (N2a) cells. However, 48 h after transfection, we
observed a dominantly nuclear distribution of NPAS4, espe-
cially under high-glucose medium conditions. We showed that
NPAS4 contains NLSs and NESs in different regions of its pro-
tein structure. Interestingly, the NLSs and NESs of NPAS4
appear as partially overlapping pairs or in close proximity. This
finding raises the possibility of alternating the activity of these
signals and suggests that the interaction of the NLS of NPAS4
with importin prevents the interaction of the NES of NPAS4
with exportin and vice versa. This dynamic may play a role in
the regulation of NPAS4 cellular shuttling. We suggest glucose
concentration as one of factors that putatively influences the
transport of NPAS4 protein. Additionally, in this study, exper-
iments with LMB revealed that the activities of NESs are
exportin-dependent.
Results
Subcellular localization of NPAS4 in COS-7 and Neuro 2a cells
Chalfie et al. (22) describe that green fluorescent protein
(GFP) can be used to monitor protein expression and localiza-
tion in living organisms. Labeling proteins with different fluo-
rescent proteins is currently a widely popular method that not
only affects the localization but also the function of fused pro-
tein (23). Twenty-four hours after transfecting COS-7 and N2a
cells, we analyzed the subcellular localization of yellow fluores-
cent protein (YFP)–tagged full-length NPAS4 and its deriva-
tives by confocal and fluorescence microscopy. The expression
of YFP-tagged NPAS4 and its derivatives in COS-7 cells was
confirmed byWestern blot analysis using an anti-GFP antibody
(Fig. S1). In our experiments using low-glucose Dulbecco’s
modified Eagle’s medium (DMEM), we noticed that the distri-
bution of full-length NPAS4 in COS-7 and N2a cells 24 h after
transfection was not exclusively nuclear. In particular, we
observed more fluorescent protein in the cytoplasm (over 80%
in COS-7 cells and 90% in N2a cells) than in the nucleus (less
than 20% in COS-7 cells and 10% in N2a cells) (Figs. 1A, a and
b, and S2A). Repeating the experiments under high-glucose
conditions, the proportion of cells with nuclear localization of
NPAS4 to cells with cytoplasmic localization of NPAS4
increased to 80/20 among COS-7 cells (Fig. 1B, a) and 30/70
among N2a cells 24 after transfection (Figs. 1C, a and a, and
S2A). Forty-eight hours after transfection, this proportion
reached 90/10 in COS-7 cells and 50/50 in N2a cells (Fig. S2A).
Expression of YFP resulted in ubiquitous localization in ana-
lyzed COS-7 cells independent of glucose concentration (Figs.
1D and S2B). Our results suggested that NPAS4 possess motifs
that function as NLSs and NESs. First, we used LMB, a known
classical NES-dependent transport inhibitor (17–19) to verify
our hypothesis regarding the presence of an NES in NPAS4.
Because we observed a decreasing number of live cells express-
ing YFP-NPAS4 after 48 h, we decided to perform further imag-
ing experiments 24 h after transfection. Additional experi-
ments in N2a cells were performed only in high-glucose
medium, whereas additional experiments in COS-7 cells were
performed in both high- and low-glucose medium. The addi-
tion of LMB to COS-7 and N2a cells resulted in strictly nuclear
localization of NPAS4 (Figs. 1B, b, 1C, b, and S3A), indicating
the inhibition of protein shuttling between the nucleus and the
cytoplasm. To prove that methanol (LMB solvent) is not
responsible for changes in protein localization after LMB addi-
tion, we used methanol alone, and we observed variable local-
ization of NPAS4 similar to the results without LMB addition
(Figs. 1B, c, 1C, c, and S3A). Interestingly, we did not observe a
simultaneous localization of full-length NPAS4 in both the cell
nucleus and cytoplasm. Retention of NPAS4 in the nucleus
after LMB addition suggested the presence of an active NLS in
this protein. To confirm that the influence of LMB on NPAS4
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subcellular localization was specific, we expressed YFP alone in
COS-7 and N2a cells and observed a ubiquitous distribution of
YFP fluorescence that was independent of the presence or
absence of LMB or methanol (Figs. 1D and S3A). Based on our
results, we hypothesized that NPAS4 contains a sequence (or
several sequences) that is responsible for its translocation to the
nucleus (NLS) and a sequence (or several sequences) responsi-
ble for its translocation to the cytoplasm.
To test this hypothesis, we performed a set of in silico analy-
ses of the NPAS4 sequence using various NLS and NES predic-
tors. Detailed results of predictions are presented in Fig. 2.
NucPred and SeqNLS did not predict any putative NLS
Figure 1. Subcellular distribution of full-length NPAS4. Expression of YFP-tagged full-length NPAS4 revealed distinct localization of fluorescence. Subcel-
lular localizationof expressedproteins inCOS-7andN2acellswas analyzedbyconfocalmicroscopy20–24hafter transfection.Nuclei andnucleoliwere stained
by Draq5. Bar, 10 m. A, representative images (single confocal plane) of the subcellular distribution of YFP-NPAS4 in COS-7 cells (a) and N2a cells (b) in
low-glucose medium. B, representative images (single confocal plane) of the subcellular distribution of YFP-NPAS4 in cells cultured in high-glucose medium.
Distribution of YFP-NPAS4 in COS-7 cells is shown under normal conditions (a), after LMB addition (b), and after methanol addition (c). C, distribution
YFP-NPAS4 in N2a cells under normal conditions (a and a), after LMB addition (b), and after methanol addition (c). D, representative images (single confocal
plane) of the subcellular distribution of YFP-NPAS4 in cells cultured in high-glucose medium. Distribution in COS-7 cells is depicted under normal conditions
(a), after LMB addition (b), and after methanol addition (c). Distribution in N2a cells is depicted under normal conditions (d), after LMB addition (e), and after
methanol addition (f).
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sequence. NLStradamus, using a cut-off value of 0.1, predicted
two potential NLS sequences encompassing amino acid (aa)
residuesGly7–Arg13 in the bHLHdomain andGlu196–Gly211 in
the PAS-2 domain (Fig. 2, top and middle). When using a low
cut-off value, cNLS Mapper identified five putative bipartite
NLSs located in the following different regions of NPAS4:
Lys10–Tyr39 and Glu19–Thr50 (bHLH domain), Arg158–Phe192
(region adjacent to PAS-2), Arg222–Trp252 (PAS-2), Arg285—
Ile316 (PAC), andGln593–Phe622 (C-terminal region) (Fig. 2, top
andmiddle). NetNES predicted residues Leu37, Ile42, and Leu45
as part of a putative NES (bHLH domain); Ile232, Glu234, and
Leu247 as a second NES (PAS-2); and Gly596 as part of a third
NES (C-terminal region) (Fig. 2, top and bottom). LocNES pre-
dicted residues Pro28–Ile42 as the first NES (bHLH) and
Met218–Val236 or Ala228–Phe242 as the second NES (PAS-2)
(Fig. 2, top and bottom). NESFinder predicted residues Ile20–
Leu29 (bHLH domain) and Leu591–Leu604 and Gly664–Leu674
(C-terminal region) (Fig. 2, top and bottom). ValidNES pre-
dicted putative NES residues Leu23–Leu29 (bHLH domain),
Leu227–Ile232 or Leu237–Phe242 (PAS-2), and Leu594–Val600
and Leu668–Leu674 (C-terminal region) (Fig. 2, top and bottom).
However, the results obtained by the different predictors were
not fully consistent.
Nevertheless, the in silico analysis suggested the presence
of NLSs in the bHLH domain, the PAS-2 domain, and the
C-terminal region of NPAS4. Accordingly, putative NESs
were expected to be located in the bHLH domain, the PAS-2
domain, and the C-terminal region of NPAS4. Interestingly,
the predicted NLS and NES motifs seemed to be located
within a very close distance, and thus we next verified these
results experimentally.
The bHLH domain of NPAS4 possesses both NLS and NES
motifs
To identify the putative NLS and NES motifs in the bHLH
domain, we generated N-terminally YFP-tagged derivatives of
the NPAS4 bHLH domain. To ensure that we did not disrupt
structural motifs within the NPAS4 sequence, truncation
mutants were designed according to the domain architecture
(1, 2, 24) and putative secondary structure motifs of this pro-
tein.We usedDraq5DNAdye to visualize the nuclei and nucle-
oli. In contrast to full-length NPAS4, the YFP-labeled bHLH
domain (Fig. 3A, YFP-NPAS4/1–59) presented a nuclear and
nucleolar distribution in COS-7 cells in low-glucose DMEM
(Fig. 3B, a and a) and in N2a cells in high-glucose DMEM (Fig.
S4). Interestingly, expression of the bHLH domain in COS-7
cells in high-glucose conditions resulted in the appearance of
few (5%) cells presentingboth cytoplasmic andnucleolar fluo-
rescence (Fig. S4). We performed an in silico prediction of the
nucleolar localization signal (NoLS) in NPAS4 with the nucle-
olar localization sequence detector (NoD) and found that the
bHLH domain was negative for any NoLS (score of 0.75). How-
ever, previously performed in silico predictions of NLSs and
NESs in NPAS4 showed that a partially overlapping NLS and
NES could be present in this region (Fig. 2). To confirm these
overlapping signals experimentally, we prepared constructs
including aa 1–40 and 26–59 (Fig. 3A). Deletion of aa 41–59
resulted in a weakening of the fluorescence signal of YFP-
NPAS4/1–40 in the nucleoli. Additionally, although this pro-
tein fragment could still enter the nucleus, it also appeared in
the cytoplasm of COS-7 and N2a cells, indicating weak NLS
signal activity, probably due to the absence of the basic amino
acids Arg51 and Lys52 (Figs. 3B, b and b, and S5). As NLS activ-
ity typically depends on the presence of basic amino acid resi-
dues (16, 25), we prepared a mutant including a 1–40–aa frag-
ment, where Arg21 and Lys24 were substituted by Ala (Fig. 3A).
The localization of this mutant shifted from predominantly
nuclear for the unmodified fragment (Figs. 3B, b, and S5) to only
slightly predominantly nuclear. Additionally, this mutant was
unequivocally excluded from the nucleoli (Figs. 3B, c, and S5),
presenting reasonably lowNLS activity and no NoLS activity in
the nucleoli. Based on the results from cNLS Mapper (Fig. 2B)
and our experiments, we concluded that the bHLH domain
contains multipartite NLS motifs comprising aa 10–52 (10KAR-
RDQINAEIRNLKELLPLAEADKVRLSYLHIMSLACIYTRK52,
where bold are basic residues and bold and underlined are basic
substituted residues). Additionally, this sequence was found to
be linkeddirectly to theNoLS, inwhich aa 51RK52 are indispens-
able for NoLS activity.
The YFP-NPAS4/26–59 truncation mutant was predomi-
nantly cytoplasmic (Figs. 3B, d, and S5) because of the predicted
NES. We then used LMB to verify the presence of NES in this
fragment. Although we observed a clear shift in localization
from cytoplasmic to predominantly nuclear (Fig. 3B, e), the
addition of methanol as a control did not influence localization
(Fig. 3B, f). As classical NES activity depends on the presence of
hydrophobic residues (usually Leu) (25), we next substituted
Leu27 and Leu29 with Ala in the 26–50–aa bHLH fragment
tagged with YFP (Fig. 3A, YFP-NPAS4/26–50/L27A/L29A).
Expression of this pointmutant resulted in fluorescence in both
the nucleus and cytoplasm as opposed to the diffuse cytoplas-
mic fluorescence of the unmodified truncatedmutant. Interest-
ingly, although protein aggregates appeared around the nuclear
membrane in some cells (Fig. 3B, g and g), these aggregates in
other cells were visible throughout thewhole cell (Fig. 3B, h and
h). This experiment proved that residues Leu27 and Leu29 are
crucial for leucine-rich NES activity in the bHLH domain.
Additionally, dominant nuclear localization of the YFP-
NPAS4/1–40 mutant (Fig. 3B, b) lacking Leu45 indicated the
Figure 2. NPAS4 schematic representation and NLS/NES prediction. Top,
schematic representation of NPAS4 protein. Regions of NPAS4 are depicted
using different patterns. The length of each domain in the diagram is arbi-
trary. Middle, results of NLS predictors, with NPAS4 amino acid residues pre-
dicted as part of NLSs. Bottom, results of NES predictors, with NPAS4 amino
acid residues predicted as part of NESs.
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importance of this amino acid residue for NES activity. Based
on results from the NetNES and LocNES predictors (Fig. 2C),
we concluded that the bHLH domain contains the sequence
26LLPLAEADKVRLSYLHIMSL45 (where bold are hydropho-
bic residues and bold and underlined are hydrophobic substi-
tuted residues) and exhibits NES activity.
Altogether, our results show that the bHLHdomain contains
two overlapping sequences that are active NLS andNESmotifs.
Additionally, nuclear and nucleolar localization motifs of the
bHLH domain of NPAS4 are directly linked.
Detection of cellular localization signals in the PAS domains of
NPAS4
To identify putative NLS and NES motifs in the PAS-1 and
PAS-2 domains, we generated the respectiveN-terminally YFP-
tagged derivatives of the PAS domains of NPAS4 and analyzed
their subcellular localization inCOS-7 andN2a cells using fluo-
rescence microscopy. For visualization of nuclei and nucleoli,
we used Draq5 DNA dye.
We found that the YFP-NPAS4/60–144 fragment contain-
ing the PAS-1 domain (Fig. 4A) expressed in COS-7 cells in
low-glucose medium was localized predominantly to the cell
nucleus (Fig. 4B, a and a), although no putative NLS was
detected by knownNLSpredictors (see Fig. 2). Additionally, the
only basic amino acid residues (characteristic of classical NLS)
present in this region were Lys93 and Arg132. Expression of this
fragment both in COS-7 and N2a cells in high-glucose DMEM
resulted in ubiquitous distribution (Fig. S4).
The fragment linking the PAS-1 andPAS-2 domains, encom-
passing aa 145 to 194 (Fig. 4A), was localized exclusively to the
nucleus of all analyzed COS-7 and N2a cells independent of
Figure 3. Subcellular distribution of the bHLHdomain of NPAS4 and their derivatives in COS-7 cells in low-glucosemedium. Subcellular localizations of the
expressed YFP-tagged proteins were analyzed by confocal microscopy 20–24 h after transfection. A, schematic representation of NPAS4 protein and YFP-tagged
derivatives of the bHLH domain. Regions of NPAS4 are depicted using different patterns. The length of each domain in the diagram is arbitrary. B, representative
images (single confocal plane) of typical (presented bymore than 95%of cells unless stated otherwise) subcellular distributions of the YFP-taggedderivatives of the
NPAS4 bHLH domain in low-glucose medium are presented. Nuclei and nucleoli were stained with Draq5. Bar, 10 m. Shown are YFP-NPAS4/1–59 (a and a),
YFP-NPAS4/1–40 (b and b), YFP-NPAS4/1–40/R21A/K24A (c), and YFP-NPAS4/26–59 (d) under normal conditions; YFP-NPAS4/26–59 after LMB addition (e); YFP-
NPAS4/26–59 aftermethanol addition (f); and prevailing patterns of YFP-NPAS4/26–59/L27A/L29A distributions (g and g, h and h).
Multiple sequences regulate NPAS4 shuttling
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glucose concentration (Figs. 4B, b and b, and S4), indicating the
presence of NLS activity. In some cells, fluorescence was also
observed in the nucleoli; however, this localization was not
present in all cells and was not as obvious as the localization
of the bHLH domain mutants (data not shown). Additionally,
the NoLS prediction results were negative. The cNLS Mapper
predictor identified the sequence 158RRQSAGNKLVLIRGRF-
HAHPPGAYWAGNPVFTAF191 as a putative NLS (Fig. 2B).
To validate this prediction, we generated a YFP-NPAS4/145–
194 constructwithR159AandK165A substitutions (Fig. 4A). In
contrast to the WT fragment, the YFP-NPAS4/145–194/
R159A/K165A mutant was localized to both compartments of
analyzed cells (Fig. 4B, c), thus confirming the switch to an
active NLS in this region.
To identify the localization of signals in the PAS-2 domain of
NPAS4,we generated aYFP-NPAS4/195–276 construct, which
is an NPAS4 fragment containing the N-terminal part of the
PAS-2 domain (Fig. 4A). This fragmentmainly exhibited a cyto-
Figure 4. Subcellular distributions of the PAS domains of NPAS4 and their derivatives in COS-7 cells in low-glucosemedium. Subcellular localizations
of the expressed YFP-tagged proteins were analyzed by confocal microscopy 20–24 h after transfection. A, schematic representation of NPAS4 protein and
YFP-tagged derivatives of the PAS domains. Regions of NPAS4 are depicted using different patterns. The length of each domain in the diagram is arbitrary.
B, representative images (single confocal plane) of typical (presentedbymore than95%ofcellsunless statedotherwise) subcellulardistributionsof theYFP-tagged
derivatives of theNPAS4 PAS domains in low-glucosemediumare presented. Nuclei and nucleoli were stainedwithDraq5. Bar, 10m. Shown are YFP-NPAS4/
60–144 (a and a), YFP-NPAS4/145–194 (b and b), YFP-NPAS4/145–194//R159A/K165A (c), and YFP-NPAS4/195–276 (d) under normal conditions; YFP-NPAS4/
195–276 after LMBaddition (e); YFP-NPAS4/195–276 aftermethanol addition (f); prevailingpatterns of YFP-NPAS4/195–276/L230A/L232A/L237Adistributions
(g, g, h, and h); YFP-NPAS4/277–340 (i and i); prevailing patterns of YFP-NPAS4/257–340/R285A/K289A distribution (j and k).
Multiple sequences regulate NPAS4 shuttling
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plasmic distribution both in COS-7 cells in low-glucose
medium (Fig. 4B, d) and inCOS-7 andN2a cells in high-glucose
medium, indicating that the presence of NES activity was con-
sistentwith theNES predictions (Fig. 2C). To verify the hypoth-
esis regarding the presence of an active NES motif within the
PAS-2 domain, we analyzed this YFP-tagged fragment using
LMB. The addition of LMB shifted the localization of the YFP-
NPAS4/195–276 fragment from cytoplasmic to slightly pre-
dominantly nuclear (Fig. 4B, e), confirming the inhibition of
the NES-exportin 1 interaction. Furthermore, the addition
of methanol as an LMB solvent did not change the cytoplas-
mic localization of YFP-NPAS4/195–276 (Fig. 4B, f), which
confirmed its lack of influence on NES activity. Analysis of
the NES prediction results led us to hypothesize that hydro-
phobic residues Leu230, Ile232, and Leu237 may be part of the
putative NES motif. To verify this hypothesis, we substituted
these residues with Ala (Fig. 4A). Surprisingly, the resulting
protein, YFP-NPAS4/195–276/L23A/I232A/L237A, seemed
to localize around the nuclear membrane of most of the ana-
lyzed cells (Fig. 4B, g). To clarify the precise localization of
the YFP-NPAS4/195–276/L230/I232/L237 mutant, we com-
pared fluorescence and transmitted light images of the same
cells (Fig. 4B, g). However, we could not definitively deter-
mine whether the expressed fluorescent aggregates were vis-
ible inside or outside the nuclear membrane or if they were
integrated into the nuclear membrane (Fig. 4B, h), despite
using Draq5 DNA dye to visualize cell nuclei (Fig. 4B, h).
Analysis of the NPAS4/195–276 fragment using NLS predic-
tors was not consistent; whereas NLStradamus predicted
Glu196–Gly211 as a putative NLS, cNLS Mapper predicted
Arg222–Trp252 as a putative NLS (Fig. 2B). Next, we gener-
ated a YFP-tagged fragment comprising aa 277–340; this
fragment consisted of the C-terminal part of the PAS-2
domain, which is also known as the PAS domain-associated
C terminus (PAC) (Fig. 4A). The YFP-NPAS4/277–340 frag-
ment was found to localize exclusively to the nucleus of all
analyzed COS-7 and N2a cells (Figs. 4B, i and i, and S4),
which is consistent with the cNLS Mapper prediction of
the 285RLQAKHGGWTWIYCMLYSDGPEGPITANNYPI316
sequence as a putative NLS (Fig. 2B). To confirm the presence
of an active NLS, we constructed a point mutant with R285A
and K289A substitutions (Fig. 4A). However, the results of
YFP-NPAS4/257–340/R285A/K289A mutant expression
were ambiguous. Three different distribution patterns were
observed, and each pattern was found in a similar number of
cells (cells with an equal distribution in both nuclear and cyto-
plasmic compartments, cells with a slightly predominantly
nuclear distribution, and cells with a predominantly nuclear
distribution (Fig. 4B, j)), whichwas in contrast to the exclusively
nuclear localization of the YFP-NPAS4/277–340 fragment
without substitutions (see Fig. 4B, i). Interestingly, in cells pre-
senting dominant nuclear localization of YFP-NPAS4/257–
340/R285A/K289A, we observed a change in the distribution
pattern in the nucleoplasm (Fig. 4B, k).
Our results showed that in the region adjacent to the PAS-2
domain and within this domain, NLS and NES sequences are
located in close proximity: NLS, 158RRQSAGNKLVLIRGRF-
HAHPPGAYWAGNPVFTAF191 (where bold are basic resi-
dues, and bold and underlined are basic substituted residues);
NES, 227LALLDISESVLITYLGF-242 (where bold are hydro-
phobic residues and bold and underlined are hydrophobic sub-
stituted residues); and putative NLS, 285RLQAKH GGWTWI-
YCMLYSDGPEGPITANNYPI316 (where bold and underlined
are basic substituted residues). Thus, in addition to the bHLH
domain, the PASdomains also seem toplay an important role in
the final NPAS4 localization.
Detection of localization signals in the C-terminal NPAS4
fragment
To test precisely for the presence of subcellular localization
signals in the C-terminal region of NPAS4 encompassing resi-
dues 341 to 802, we analyzed fragments of this region sepa-
rately. These NPAS4 fragments were defined according to the
secondary structure prediction, which was performed using
PSIPRED. Eventually, five fragments encompassing residues
341–460, 461–580, 581–650, 650–720, and 721–802 were
selected. YFP-tagged NPAS4/341–460 (Fig. 5A) was distrib-
uted ubiquitously throughout the whole cell, both in COS-7
cells independent of glucose concentration and in N2a cells
(Figs. 5B, a, and S6). As no NLS or NES motif was predicted in
this area, this result proved the lack of subcellular localization
signals in this region. Surprisingly, the next fragment, YFP-
NPAS4/461–580 (Fig. 5A), localized to the cytoplasm both in
COS-7 cells independent of glucose condition and in N2a cells
(Figs. 5B, b, and S6). The addition of LMB shifted the localiza-
tion of YFP-NPAS4/461–580 to the nucleus (Fig. 5B, c), thus
proving the presence of an active NES motif interacting with
exportin 1. Methanol, which was used as a control, did not
influence localization (Fig. 5B, d). Interestingly, none of the
NES predictors suggested the presence of a putative NES motif
in this fragment. We decided to investigate the effect of trun-
cation by creating a YFP-NPAS4/341–580 construct (Fig. 5A)
including a fragment with cytoplasmic localization (YFP-
NPAS4/461–580) and a fragment with ubiquitous localization
(YFP-NPAS4/341–460). Expression of this combined YFP-
NPAS4/341–580 fragment, containing both previously tested
fragments, resulted in fluorescence in both cellular compart-
ments (cytoplasm and nucleus) (Figs. 5B, e, and S7). We
hypothesized that some residues in the 341–460–aa fragment
deactivate the putative NES in the 461–580–aa fragment by
interacting with an unknown factor, thus masking the NES. As
a typical NES sequence is rich in Leu residues, we performed
additional analyses of the sequence of this region (aa 461–580).
However, we did not find any obvious cluster of Leu residues,
and we were unable to identify the sequence possessing NES
activity in this fragment. The localization of YFP-NPAS4/581–
650 (Fig. 5A) was cytoplasmic in all analyzed cells, both in low-
and high-glucose medium (Figs. 5B, f, and S6); this result is in
full agreement with most NES predictors identifying amino
acid residues between Leu591 and Leu604 as a putative NES
motif (see Fig. 2). Moreover, the addition of LMB shifted the
cytoplasmic fluorescence of this mutant to a predominantly
nuclear localization (Fig. 5B, g). Methanol addition did not
change the localization of the fluorescence signal (Fig. 5B, h).
Next, we examined this fragment by substituting amino acid
residues suspected to be part of the hypothesized NES motif.
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We substituted Leu591, Leu594, and Leu598 with Ala (Fig. 5A)
and observed a clear shift in fluorescence to the nucleoplasm
upon expression of the YFP-NPAS4/581–650/L591A/L594A/
L598Amutant (Fig. 5B, i), indicating deactivation of NES activ-
ity. This result confirmed that the predicted sequence,
591LAQLRGPLSV600, is an active NES. To better explain the
nuclear localization of this mutant, we further analyzed results
from the NLS predictions. cNLS Mapper predicted the sequence
593QLRGPLSVDVPLVPEGLLTPEASPVKQSFF622 as a putative
NLS (Fig. 2). This sequence partially overlappedwith a region that
was previously identified to contain an NES (591–600 aa) but
seemed to act predominantly as an NLS. As we were interested in
the influence of additional amino acid residues on NLS and NES
activities, we generated YFP-tagged combined fragments YFP-
Figure 5. Subcellular distribution of the C-terminal part of NPAS4 derivatives in COS-7 cells in low-glucose medium. Subcellular localizations of the
expressed YFP-tagged proteins were analyzed by confocal microscopy 20–24 h after transfecting COS-7 cells in low-glucosemedium. A, schematic represen-
tation of NPAS4 protein and YFP-tagged derivatives of NPAS4 C terminus. Regions of NPAS4 are depicted using different patterns. The length of each domain
in the diagram is arbitrary. B, representative images (single confocal plane) of typical (presented by more than 95% of cells) subcellular distributions of the
YFP-tagged derivatives of the NPAS4 C terminus are presented. Bar, 10 m. Shown are YFP-NPAS4/341–460 (a) and YFP-NPAS4/461–580 (b) under normal
conditions; YFP-NPAS4/461–580 after LMB addition (c); YFP-NPAS4/461–580 after methanol addition (d); YFP-NPAS4/341–580 (e) and YFP-NPAS4/581–650
under normal conditions (f); YFP-NPAS4/581–650 after LMB addition (g); YFP-NPAS4/581–650 after methanol addition (h); YFP-NPAS4/581–650/L591A/
L594A/L598A (i) and YFP-NPAS4/461–650 under normal conditions (j); YFP-NPAS4/461–650 after LBM addition (k); YFP-NPAS4/461–650 after methanol
addition (l); YFP-NPAS4/581–720 (m); YFP-NPAS4/651–720 (n); YFP-NPAS4/721–802 (o); and YFP-NPAS4/651–802 (p).
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NPAS4/461–650 and YFP-NPAS4/581–720 (Fig. 5A) containing
both detected signals. Expression of YFP-NPAS4/461–650
resulted in exclusive cytoplasmic fluorescence in COS-7 cells
both in low- and high-glucose conditions and inN2a cells (Figs.
5B, j, and S7), thus predominantly presenting characteristics of
the NES in the tested region. The addition of LMB resulted in
the uniform localization of the mutant in both compartments
of COS-7 cells in low-glucose medium and in N2a cells (Figs.
5B, k, and S3B); however, in high-glucose DMEM, we observed
an evident shift in localization of the expression of this frag-
ment to the nucleus after LMBaddition (Fig. S3B).We expected
exclusive nuclear localization of YFP-461–650 after LMB addi-
tion because the Leu594–Phe622 sequence present in this frag-
ment was a predicted NLS and was putatively responsible for
the nuclear localization of the YFP-NPAS4/581–650/L591A/
L594A/L598Amutant. Therefore, we have no clear explanation
for the different localization behavior observed in COS-7 cells
depending on glucose concentration. One possibility is that the
presence of additional amino acid residues (aa 461–580) results
in NLS activity inhibition in low-glucose medium via an
unknown mechanism. The methanol control did not influence
localization (Fig. 5B, l). Expression of the YFP-NPAS4/581–720
fragment (Fig. 5A) resulted in ubiquitous fluorescence in both
the nucleus and the cytoplasm of the analyzed cells (Figs. 5B,m,
and S7). Thus, in this mutant, the strength of the NLS and NES
activity seems to be balanced. Next, we expressed NPAS4 frag-
ments YFP-NPAS4/651–720 and YFP-NPAS4/721–802 (Fig.
5A), and these fragments localized to both the nucleus and the
cytoplasm (Figs. 5B, n and o, and S6). We then fused these
fragments and found that the combined YFP-NPAS4/651–802
fragment (Fig. 5A) localized to both cellular compartments,
with a slightly more robust fluorescent signal in the nucleus
(Figs. 5B, p, and S7). This result is inconsistent with the predic-
tion results, such that ValidNES identified the Leu668–Leu674
sequence and NESFinder identified the Gly664–Leu674
sequence as putative NES motifs (see Fig. 2). Therefore, these
results verified that this sequence is not an active NES and that
its activity is inhibited by an unknown factor.
Altogether, our results show that the C-terminal region of
NPAS4 contains two overlapping sequences: 591LAQLRG-
PLSV600 (bold and underlined are hydrophobic substituted res-
idues) is an active NES and 593QLRGPLSVDVPLVPEGLLT-
PEASPVKQSFF622 (bold is the only basic residue) is a putative
NLS.Additionally, we detectedNES activity in the 460–580–aa
region of the C-terminal part of NPAS4, but we were unable to
identify the sequence responsible for directing this fragment to
the cytoplasm. Thus, we believe that in addition to the bHLH
and PAS domains, the C terminus of NPAS4 contributes to the
regulation of NPAS4 shuttling in response to different stimuli.
The hierarchy of the cellular localization signals in NPAS4
As we detected more than one NLS and one NES in NPAS4,
we next investigated the interplay of NPAS4 localization sig-
nals. We generated YFP-tagged derivatives of NPAS4 contain-
ing different domains and analyzed their subcellular localiza-
tion in COS-7 and N2a cells. The expression of YFP-tagged
derivatives in COS-7 cells was confirmed byWestern blot anal-
ysis using an anti-GFP antibody (see Fig. S1). To visualize the
nuclei and nucleoli, we used Draq5 DNA dye. First, we sought
to verify the hierarchy of signals in the N-terminal part of
NPAS4. By tagging with YFP, we prepared fragments contain-
ing the bHLH and PAS-1 domains (Fig. 6A, a, YFP-NPAS4/1–
144); the PAS-1 domain and a linker between the PAS-1 and
PAS-2 domains (Fig. 6A, b, YFP-NPAS4/60–195); a linker
between thePAS-1 andPAS-2 domains connected to theN-ter-
minal part of the PAS-2 domain (Fig. 6A, c, YFP-NPAS4/145–
276); the PAS-2 domain (Fig. 6A, d, YFP-NPAS4/195–340); a
linker between the PAS-1 and PAS-2 domains combined with
the PAS-2 domain (Fig. 6A, e, YFP-NPAS4/145–340); and the
N-terminal part of NPAS4 containing the bHLH, PAS-1 and
PAS-2 domains with a linker (Fig. 6A, f, YFP-NPAS4/1–340).
The results of the expression of YFP-NPAS4/1–144 (Fig. 6A,
a) and YFP-NPAS4/60–195 (Fig. 6A, b) fragments could not be
easily interpreted because they were not fully consistent with
our expectations. We observed predominantly cytoplasmic
localization (90%) in COS-7 and N2a cells in both low- and
high-glucose medium (Figs. 6B, a, a, b, and b, and S8 and S9).
Interestingly, in the case of YFP-NPAS4/1–144, few cells
(10%) presented simultaneous cytoplasmic and nucleolar
localization (Fig. S9). Nucleolar and nuclear localization of
YFP-NPAS4/1–144 could be interpreted easily because NLS-1
linked with NoLS in the bHLH domain and was dominant over
NES-1 in the YFP-NPAS4/1–59–expressing fragment (see Fig.
3B, a), similar to the nuclear localization of YFP-NPAS4/60–
195 comprising NLS-2 in the linker between the PAS domains
(see Fig. 4B, b). However, we cannot provide a clear explana-
tion for the cytoplasmic localization of the 1–144–aa and
60–194–aa fragments. The PAS-1 domain (60–144 aa), which
is responsible for the cytoplasmic shift for both of these frag-
ments, did not present any subcellular localization signal activ-
ity in our previous experiments (see Fig. 4B, a).
Strictly nuclear localization of the expressed YFP-NPAS4/
145–276 fragment containing NLS-2 and NES-2 (Fig. 6A, c) in
COS-7 and N2a cells (Figs. 6B, c and c, and S8 and S9) showed
thatNLS-2 is dominant overNES-2. Similarly, the expression of
YFP-NPAS4/195–340 (PAS-2 domain) containing NES-2 and
NLS-3 (Fig. 6A, d) led to the observation of fluorescence in the
nuclei of both of the cell types tested (Figs. 6B, d and d, and S8
and S9), pointing to the dominant character of NLS-3 over
NES-2. The fusion of these fragments in the YFP-NPAS4/145–
340 construct comprisingNLS-2, NES-2, andNLS-3 (Fig. 6A, e)
resulted in the expected nuclear localization of the expressed
protein in COS-7 and N2a cells (Figs. 6B, e and e, and S8 and
S9), proving the dominant characters of bothNLS-2 andNLS-3
overNES-2. These resultswere independent of the glucose con-
centration used. Nuclear localization of the expressedN-termi-
nal part ofNPAS4 (Fig. 6A, f, YFP-NPAS4/1–340) inCOS-7 and
N2a cells (Figs. 6B, f and f, and S8 and S10A) revealed a conse-
quent domination of NLSs (NLS-1, NLS-2, and NLS-3) in this
part of the protein.
Next, we evaluated the subcellular distribution of the
NPAS4/1–580 fragment, which was attached to the previous
fragment by 341–580 aa, containing NES-3 (Fig. 6A, g). Expres-
sion in both low- and high-glucose medium resulted in domi-
nant nuclear localization of the expressed protein inCOS-7 and
N2a cells (Figs. 6B, g and g, and S8 and S10A), indicating the
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domination of NLSs (NLS-1, NLS-2, and NLS-3) from the
N-terminal part of NPAS4 over NES-3.
To test the hierarchy of the signal in the C-terminal part of
NPAS4, we prepared the YFP-NPAS4/341–802 construct con-
tainingNES-3,NLS-4, andNES-4 (Fig. 6A,h). Expression of this
fragment resulted in cytoplasmic localization in COS-7 and
N2a cells independent of the glucose concentration (Figs. 6B, h
and h, and S8 and S10A). This result is consistent with the
cytoplasmic distribution observed previously for the expression
of YFP-NPAS4/581–650 (see Fig. 5B, f) and indicated domina-
tion of NES-4 over NLS-4.
To verify the hierarchy of dominant NLSs from the N-termi-
nal part of NPAS4 and dominant NESs from the C-terminal
part of NPAS4, we created NPAS4 with deletion of the bHLH
domain (YFP-NPAS4/60–802) (Fig. 6A, i). The expressed pro-
tein was localized strictly in the cytoplasm of N2a cells in both
low- and high-glucose medium (Figs. 6B, i, and S8 and S10, A
and B). Interestingly, expression of this construct in COS-7
cells resulted in cytoplasmic localization in the condition of
low-glucose medium (Figs. 6B, i, and S8 and S10B), whereas
high-glucose medium resulted in a localization shift to 80%
cytoplasmic and 20% nuclear (Fig. S10A). This result proves
Figure 6.HierarchyofNLSandNES signals inNPAS4. Subcellular localizations of the expressed YFP-taggedderivatives of NPAS4were analyzedby confocal
microscopy 20–24 h after transfectingCOS-7 andN2a cells.A, schematic presentation of NPAS4 andYFP-taggedNPAS4derivatives. B, subcellular distributions
of YFP-tagged derivatives of NPAS4. Representative images (single confocal plane) of typical (presented by more than 95% of cells unless stated otherwise)
subcellular distributions of the NPAS4 derivatives are presented. Nuclei and nucleoli were stained by Draq5. Bar, 10 m. Distributions in COS-7 cells in
low-glucose medium: YFP-NPAS4/1–144 (a), YFP-NPAS4/60–144 (b), YFP-NPAS4/145–276 (c), YFP-NPAS4/195–340 (d), YFP-NPAS4/145–340 (e), YFP-NPAS4/
1–340 (f), YFP-NPAS4/1–580 (g), YFP-NPAS4/341–802 (h), andYFP-NPAS4/60–802 (i). Distributions inN2acells inhigh-glucosemedium:YFP-NPAS4/1–144 (a),
YFP-NPAS4/60–144 (b), YFP-NPAS4/145–276 (c), YFP-NPAS4/195–340 (d), YFP-NPAS4/145–340 (e), YFP-NPAS4/1–340 (f), YFP-NPAS4/1–580 (g), YFP-
NPAS4/341–802 (h), and YFP-NPAS4/60–802 (i).
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that NESs from the C terminus of NPAS4 (definitively NES-4
and possibly NES-3) are dominant over bothNLS-2 andNLS-3,
which are dominant over NES-2. However, this domination
may be dependent on the cell type and the glucose concentra-
tion used. As full-length NPAS4 localization is distributed
between the nucleus and the cytoplasm depending on the glu-
cose level in the medium and on the cell type (see Fig. 1), we
suggest that the domination of NLS-1 from the bHLH domain
over NESs from the C-terminal part of NPAS4 relies on various
glucose level–dependent factors.
Discussion
The eukaryotic cell is organized into membrane-covered
compartments performing biochemically distinct cellular pro-
cesses andpossessing specific sets of proteins. Subcellular local-
ization determines the access of proteins to interacting partners
and the possibility of posttranslationalmodifications. The inap-
propriate localization of proteins has been linked to many
human diseases, such as Alzheimer’s disease, kidney stones,
and cancer (26). As subcellular distribution is a key factor for
the proper function of bHLH-PAS proteins (27), we performed
a detailed characterization of the sequences responsible for
NPAS4 protein transport between the cytoplasm and the
nucleus.
We show here that the bHLH domain of NPAS4, responsible
for ARNT binding and interaction with DNA, contains NLS-1
and overlapping NES-1 (Fig. 7A). Interestingly, our data indi-
cate that NLS-1 is linked directly with NoLS. Based on our
results, we hypothesized that the bHLHdomain is an important
player in the dynamic exchange of NPAS4 between subcellular
compartments. Additionally, we documented the presence of
NLS-2 and NES-2 sequences located in close proximity to the
PAS-2 domain, which is usually responsible for ligand binding
and sensing environmental cues. In the C-terminal region of
the PAS-2 domain, also known as PAC, we hypothesize the
presence of NLS-3. Until now, ligand binding by the PAS
domains of NPAS4 has not been tested. In searching for an
explanation for the biological significance of the presence of
NLSs and NESs in PAS domains, we performed predictions of
NPAS4 ligand binding using the 3DligandSite server. The
results of our predictions suggest the possibility that the PAS-1
Figure 7. Summary ofNLSs andNESs inNPAS4.A, schematic representation of NLSs andNESs residingwithin theNPAS4 protein structure. B, NLSs andNESs
presented in a 3D model of NPAS4 generated by Phyre2 (59). Residues 1–340 encompassing the bHLH and PAS domains of NPAS4 were modeled with
confidencehigher than90%using the templates c4f31B, c4zprB, C4f31A, c4zp4D, c5sy5Bandc5sy7B. TheC-terminal regionofNPAS4 lackingany template and
predicted as disordered was modeled ab initio (67% of the protein is predicted as disordered). NLS-1, NLS-2, and putative NLS-3 and NLS-4 are shown in blue.
NES-1, NES-2, NES-3, and NES-4 are shown in red. The unique mammalian NPAS4 with sequence rich in PG and PR repeats, where the Pro201 residue was
predicted (probability 0.85, HydroxyPred) as the site of hydroxylation (197PRPRPGPGPGPGPGP211), is shown in yellow.
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and PAS-2 domains bind to heme and flavin mononucleotide
(FMN), which is consistent with the results ofWu et al. (5), who
found that mammalian bHLH-PAS transcription factors bind
multiple ligands. Furthermore, our hypothesis of an interaction
with heme is substantiated by the fact that heme binding was
documented for the PAS domains of another neuronal PAS
domain–containing protein, NPAS2. Heme binding by NPAS2
forms a gas-regulated sensor; however, the natural ligand is
currently unknown (28). FMN is present in light–oxygen–
voltage (LOV) proteins, which belong to the PAS family, as a
chromophore involved in blue-light absorption that is impor-
tant, for example, in regulating circadian rhythms (29). The
predicted ligand binding by the PAS-2 domain occurs partially
via amino acids located in regions of detected NLS and NES
sequences: NLS-2 (Thr189 and Phe191), NES-2 (Leu227), and
NLS-3 (Arg285, Leu286, Ile296, Cys298, Leu300, Ile309, Thr310,
Ala311, and Asn313); this suggests ligand binding–dependent
regulation of NPAS4 subcellular localization. Interestingly,
Western blot analysis of expressedWTPAC fused toYFP (YFP-
NPAS4/277–340) resulted in the dual band (discussed later)
migratingmore slowly than expected (apparentmolecularmass
of the band of 45 kDa but an expected molecular mass of 34
kDa) (Fig. S1B). The substitution of Arg285 by alanine in the
YFP-NPAS4/257–340/R285A/K289A mutant abolished this
discrepancy, and Western blot analysis showed one band with
an apparent molecular mass corresponding to the expected 36
kDa (Fig. S1D), which substantiates the hypothesis regarding
the role of Arg285 in the ligand binding. Using the nine-amino-
acid transactivation domain prediction tool (9aaTAD, data not
shown),we found a perfectmatch for 9aaTADencompassing aa
276–284, located next to NLS-3, which raised the possibility of
connections among sensing the environment by ligand (i.e.
heme) binding, the regulation of NLS-3 activity, and the inter-
action of 9aaTAD with the transcription machinery (30).
The presence of multiple opposing and partially overlapping
localization signals suggests a complex mode of regulation of
NPAS4 shuttling in response to different factors. NLS and NES
sequences are short linear motifs. The preferential location of
thesemotifs in the intrinsically disordered regions (IDR) of pro-
teins has been found to enable flexible and easily accessible
interactions with their binding partners (31). To substantiate
our results, we performed predictions of NPAS4 disorder, and
67% of the NPAS4 sequence (mostly C-terminal) was predicted
to be disordered (data not shown). As the structure of NPAS4 is
unknown, we used Phyre2 to generate a molecular model of
NPAS4 to predict the surface exposure of defined sequences.
Localization signals can be structurally exposed and accessible
to transport machinery or masked by interacting partners. The
NLSs andNESs thatwe detected in the bHLHandPASdomains
were located in or adjacent to short disordered regions, provid-
ing some degree of flexibility, despite their location in ordered
domains. We believe that the location of NES-3, NES-4, and
NLS-4 in the C-terminal, as a long IDR of NPAS4, serves to
enhance flexibility and precise mechanistic control of NPAS4
activity in the context of interactionswith its coactivators/core-
pressors. Interestingly, when we analyzed the predicted 3D
NPAS4 model (see Fig. 7B) in the context of the distribution of
NLSs and NESs, we observed that NLS-1 and NES-1 in the
bHLH domain were easily accessible for interaction with the
partners. In contrast, other signals were located in areas that
can exist in multiple conformations adopted by the disordered
NPAS4C terminus and, in this way, influence the exposure and
accessibility of signals in the C-terminal part of the protein.
Additionally, Fig. 7B presents the unique mammalian NPAS4
sequence rich in PG and PR repeats, in which we predicted
Pro201 (probability 0.85) as the site of hydroxylation. Interest-
ingly, this sequence in the 3D model is located as a linker
between the N-terminal and C-terminal structural parts of
NPAS4 and is highly exposed. We hypothesize that this site
might serve as a site for hydroxylation and subsequent ubiqui-
tin-mediated degradation.
IDRs are known targets of intensive posttranslational modi-
fications (PTM). Modifications such as phosphorylation, espe-
cially near theNLS or theNES, have been shown to regulate the
intracellular distribution of proteins by activating or deactivat-
ing the localization motifs (32). We performed predictions for
NPAS4 phosphorylation sites and found that 62 serine residues
of NPAS4 are phosphorylated with a probability higher than
0.9. Some of the predicted serine residues were found in the
NLSs or NESs, and some were found to be located in close
proximity to thesemotifs: Ser156, Ser161 (NLS-2), Ser233, Ser235,
Ser245 (NES-2), Ser302, Ser317 (NLS-3), and Ser615 (NLS-4); this
suggests that phosphorylation is an influencing factor of
NPAS4 localization. Choy et al. (33) suggest that NPAS4 in
neuronal cells is phosphorylated by a member of the MAPK
family. Interestingly, Western blot analysis showed the pres-
ence of dual bands for expressed YFP-NPAS4/277–340 (the
area comprising NLS-3) and YFP-NPAS4/581–650 (the area
comprising NES-4 and NLS-4) (Fig. S1B), which additionally
supports our hypothesis regarding the role of PTMs.
We observed that NPAS4 is localized in the nucleus or the
cytoplasmofCOS-7 andN2a cells. The proportion of nuclear to
cytoplasmic NPAS4 depended on the glucose concentration in
the medium. Furthermore, cytoplasmic localization of NPAS4
was LMB-sensitive. The reasons behind these differences in
results obtained from experiments of full-length NPAS4 per-
formed in media with different concentrations of glucose
remain unknown. The low-glucose medium used in our exper-
iments (4.5 mM) corresponded to the concentration of glucose
in normalmetabolism,whereas the high-glucose concentration
(25mM) corresponded to diabetes. NPAS4was shown to be one
of the immediate early genes (IEG) that activate mechanisms
related to the first defense against many cellular stresses (34).
Interestingly, immediate early genes are regulated by a specific
stimulus without de novo synthesis protein (35). Shamloo et al.
(20) propose that cytoplasmic NPAS4 in brain cells serve as a
source for translocation to other cellular compartments after
ischemia, a finding that could suggest a role for NPAS4 shut-
tling in cells. Previous studies have demonstrated that glucose
depolarization rapidly induces NPAS4 expression in murine
and human pancreatic islets (11). Additionally, NPAS4 has
been shown to be indispensable for the depolarization-depen-
dent induction of almost 300 genes in the brain. Interestingly,
for someof these genes,NPAS4 appears to be a dual regulator of
transcription, with the ability to both induce and repress down-
stream gene expression (36). Odor-induced expression of
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NPAS4 in the olfactory bulb suppresses E3 ubiquitin-protein
ligase Mdm2 expression (37). Additionally, in pancreatic cells,
NPAS4 inhibits insulin gene activation (7).
As transcription factors, NPAS4 should be located in the
nucleus to control gene transcription; however, the exclusion of
transcription factors from the nucleus is a known mechanism
that regulates their activity. For example, the regulation of
HIF-1 includes compartmentalization of proteasome-depen-
dent degradation activity and subcellular distribution of this
protein (25). HIF-1 contains oneNLS in its bHLHdomain and
oneNLS in its C terminus, which is responsible for transporting
HIF-1a to the nucleus when exposed to hypoxia (38). NPAS4 as
a heterodimer with ARNT2 has been shown to activate the
transcription of brain-derived neurotrophic factor (BDNF)
(39). As ARNT2 is a strictly nuclear protein (40), the regulation
of the nuclear localization of NPAS4 could be the limiting fac-
tor in transcription activation of BDNF, homeostatic genes in
neurons, and other downstream targets such as VE-cadherin in
endothelial cells (8).
The role of NPAS4 in many different cellular processes sug-
gests additional roles for the cytoplasmic localization of this
protein. NPAS4 recently was shown to induce autophagy in rat
primary cortical neurons and to degrade Tau proteins involved
in the pathogenesis of Alzheimer’s disease and other tauopa-
thies through an unknownmechanism (13). It was also recently
documented that MAGED1 interacts with NPAS4 and pro-
motes the activation of reporter genes. Interestingly, MAGED1
(a cytoplasmic protein) does not compete with ARNT or
ARNT2 (nuclear proteins). It is proposed that the interaction
between MAGED1 and the activated bHLH-PAS factor occurs
prior to NPAS4 nuclear import and indirectly affects protein
activity, probably via PTMs (21).
Our data indicate that glucose concentration could be one of
the factors influencing NPAS4 localization. One of the post-
translational modifications initiated by high-glucose concen-
tration is the enhanced protein O-glycosylation on Ser or Thr
residues. This PTM can enhance glucotoxicity by impairing
protein function and has been demonstrated to be involved in
the insulin resistance and pathogenesis of diabetes (41). Inter-
estingly, the prediction results for NPAS4 revealed a high prob-
ability of 0.8 for the O-glycosylation of Ser4 (bHLH), a 0.72
probability for Thr333 (PAS-2), and a0.9 probability formany
Ser and Thr residues in the C-terminal part of the protein,
pointing to the possibility that these PTMs contribute to the
regulation of NPAS4 localization and activity.
Herein, we have presented the first study of the presence of
NoLS, NLS, and NES sequences in NPAS4. The alignment of
NPAS4 amino acid sequences from Rattus norvegicus and
Homo sapiens shows very high conservation, especially in the
regions of the detected NLSs and NESs, indicating their impor-
tance for protein functionality (31). We show that NPAS4 is a
shuttling protein with a very complicated and precise regula-
tion of subcellular localization. The disordered character of the
NPAS4 C terminus may serve as a platform for simultaneous
interactions with many partners; this method of interaction
may be responsible for the very precise andmultifactor-depen-
dent regulation of NPAS4 trafficking andmay be crucial for the
ability of NPAS4 to act as a biological sensor and switch to
modulate the cross-talk of different signaling pathways. Our
data indicate that glucose concentration could be one factor
influencingNPAS4 localization by regulatingNPAS4 activity as
a transcription and cytoprotective factor. We hypothesize that
the activation of NPAS4 transcription activity is dependent on
its localization, ligand binding, and PTMs. Additional, more
detailed studies are necessary to fully elucidate the regulation
and different functions of NPAS4 in the cytosol, nucleus and
other possible cellular compartments.
Experimental procedures
Plasmid construction
NPAS4 cDNA from R. norvegicus was a kind gift from Prof.
Michael E. Greenberg (Harvard Medical School, Boston). Full-
length cDNA encoding amino acid residues 1–802 was ampli-
fied by PCR and cloned into the EcoRI and SalI restriction sites
of the MCS of the pEYFP-C1 vector (Clontech). Deletion
mutants of NPAS4 were similarly cloned into the pEYFP-C1
vector. The point mutants YFP-NPAS4/1–40/R21A/K24A,
YFP-NPAS4/26–59/L27A/L29A, YFP-NPAS4/145–194/R159A/
K165A, YFP-NPAS4/195–276/L230A/I232A/L237A, YFP-
NPAS4/277–340/R285A/K289A, and YFP-NPAS4/581–650/
L591A/L594A/L598A were obtained by PCR-mediated site-
directed mutagenesis as described by Ko andMa (42) and cloned
withLguI,EcoRI, andSalI restrictionenzymes.All constructswere
verified by DNA sequencing.
Cell culture and DNA transfection
African green monkey kidney fibroblasts COS-7 (ATCC
CRL-1651) and mouse albino neuroblastoma N2a cells
(ECACC, Sigma-Aldrich) were cultured in DMEM with 1.0
or 4.5 g/liter glucose and L-glutamine (Lonza). The culture
medium was supplemented with 10% fetal calf serum (FCS).
Cells were cultured at 37 °C in a 95% air, 5% CO2 atmosphere.
Cells were transfected with 3 g of DNA/150,000 cells using
XfectTM transfection reagent (Takara Clontech) according to
the manufacturer’s instructions. LMB (Sigma) was dissolved in
70% methanol at a concentration of 103 M and added to the
medium during transfection at a final concentration of 106 M.
Electrophoresis andWestern blot analysis
To confirm the expression of NPAS4 and NPAS4mutants in
cultured cells in parallel with the microscopy experiments,
SDS-PAGE andWestern blot analysis were performed (Fig. S1).
Samples of total protein extract were prepared by replacing the
cell medium 24 h after transfection (after washing cells with
PBS) with 2 SDS gel–loading buffer (43), transferring extracts
to Eppendorf tubes, boiling samples for 5 min, and then centri-
fuging samples for 5 min (13,000 g). Proteins were separated
by 10% SDS-PAGE and transferred to a Whatman Protran
nitrocellulose transfer membrane (Protran BA85, Schleicher &
Schuell Pure, Sigma-Aldrich) with amini Trans-Blot apparatus
(Bio-Rad). The membrane was blocked at room temperature
for 1 h in 3% milk blocking buffer (milk powder, Milchpulver,
blotting grade, Roth) prepared in PBS supplemented with 0.2%
Tween 20 (Sigma). Next, the membrane was incubated over-
night at 4 °C with anti-GFP polyclonal antibodies (Clontech)
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(diluted 1:300 with milk buffer), which cross-react with YFP.
Secondary goat anti-rabbit antibodies coupled to horseradish
peroxidase (Vector Laboratories) were added (1:10,000 with
milk buffer) and incubated at room temperature for 2 h. Blots
were developed using Pierce ECL Plus Western blotting sub-
strate (Thermo Scientific) according to the manufacturer’s
manual.
Microscopy imaging
As described previously (44), prior to confocal microscopy
imaging experiments, cells were seeded onto 0.17-mm–thick
round glass coverslips (Menzel) and submerged in culture
medium in 2-cm–diameter Petri dishes. Next, 20–24 h after
transfection, the coverslips with the cell cultures were trans-
ferred onto a steel holder and mounted on a microscope stage.
For COS-7 cells, the standard culture medium was replaced
with 1 ml of DMEM/F12 without phenol red, buffered with 15
mM HEPES (Sigma), and supplemented with 2% fetal bovine
serum (FBS, Sigma). Next, 0.25 l of Draq5 DNA dye (Bio-
Status) was added to the cells for DNA visualization. During
microscopy, the cell culture temperature was stabilized at 37 °C
using a microincubator (Life Imaging Services, Box & Cube).
Images of fluorescently labeled proteins were acquired using a
Leica TCS SP5 II confocal system equipped with argon and
helium neon lasers and a 63 oil objective lens (numerical
aperture 1.4). YFP was excited using 514 nm light, and emitted
fluorescence was observed in the range of 525 to 600 nm. The
excitation wavelength of Draq5 was 633 nm, and emission was
detected at 650 to 800 nm. Gamma correction of 0.6 was set for
images with Draq5 dye. Fluorescence microscopy was per-
formed in 2-cm–diameter Petri dishes in low- or high-glucose
DMEMusing anOlympus IX71microscope with a YFP filter at
24 or 48 h after transfection. At least 50 cells were observed for
each cDNA construct in one experiment, and at least three
independent experiments were performed for each cDNA con-
struct. Images are presented for representative cells with a typ-
ical phenotype characteristic of more than 95% of the cells. For
those cells presenting many phenotypes, representative images
of all cell phenotypes are presented.
In silico analysis of the NPAS4 sequence
PSIPRED (Protein Structure Prediction Server) (45)was used
to predict the secondary structure of NPAS4. NPAS4 domain
architecture was predicted using SMART (simple modular
architecture tool (46), http://smart.embl-heidelberg.de)3 and
PROSITE (a database of protein families and domains, http://
expasy.org/tools/scanprosite/). Sequence alignments were
obtained using ClustalX (47) (http://www.clustal.org/). Predic-
tions for potential NLS sequences were performed using
NucPred (48), PSORTII (49) (http://www.psort.org/), cNLS
Mapper, and NLStradamus (50) (http://www.moseslab.csb.
utoronto.ca/NLStradamus/). Predictions of potential NoLS
motifs were performed using NoD (nucleolar localization
sequence detector, http://www.compbio.dundee.ac.uk/www-
nod/) (51, 52, 63, 64). Predictions of potential NES sequences
were performed using NetNes 1.1 server (53) (http://www.cbs.
dtu.dk/services/NetNES/); ValidNES (54) http://validness.
ym.edu.tw); NES Finder 0.2 (http://research.nki.nl/fornerodlab/
NES-Finder.htm); and LocNES (55) (http://prodata.swmed.edu/
LocNES/LocNES.php). Predictions of NPAS4 phosphorylation
sites were performed using KinasePhos2.0 (56) (http://
kinasephos2.mbc.nctu.edu.tw/); and 9aaTAD predictions were
performed using the 9aaTAD prediction tool (moderately
stringent patterns were used, which are known to be best for
mammalian transcription factors (30)) (http://www.med.
muni.cz/9aaTAD/). Predictions of protein disorder were per-
formed using VL3 predictor of intrinsically disordered regions
(57, 58) (http://www.dabi.temple.edu/disprot/predictor.php).
The NPAS4 rat model was generated using Phyre 2 (59). Resi-
dues 1–340 encompassing the bHLH and PAS domains of
NPAS4 were modeled with confidence higher than 90% using
the following templates: c4f31B, c4zprB, C4f31A, c4zp4D,
c5sy5B, and c5sy7B. C-terminal regions of NPAS4 lacking any
template and predicted as disordered were modeled ab initio,
which was highly unreliable. Ligand binding sites were pre-
dicted using the 3DLigandSite Web server (60) (http://www.
sbg.bio.ic.ac.uk/3dligandsite) for the Phyre2-generated model
of NPAS4 residues 1–340.
Predictions of O-glycosylation sites were performed using
the NetOGlyc 4.0 server (61) (http://www.cbs.dtu.dk/services/
NetOGlyc/). Predictions of hydroxylation sites were performed
using PredHydroxy:Prediction of Protein Hydroxylation site
(62).
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